Clinical implications of interleukins-31, 32, and 33 in gastric cancer

Figure 4 Correlation of interleukin-32 and interleukin-33 expression with sex. A-D: Positive (brown) interleukin (IL)-32 expression in gastric cancer tissues from female (A) vs male (B) patients and noncancerous tissues (C) plus quantified data (D); E-H: Positive (brown) IL-33 expression in gastric cancer tissues from female (E) vs male (F) patients and noncancerous tissues (G) plus quantified data (H). IL-32 and IL-33 both decreased in female patients with gastric cancer. ^aP < 0.001; ^bP < 0.05; ^cP < 0.0001; ^dP < 0.01; ^eP < 0.05. IL: Interleukin.